1. A particular congenital malformation related to misoprostol?

   Newsletter Article 31 January 2013 Pages: 1 - 1

2. The risks may outweigh the benefits of cyclosporin therapy in psoriasis

   Newsletter Article 31 January 2013 Pages: 1 - 1

3. Antipsychotic elixirs form precipitates with coffee and tea

   Newsletter Article 31 January 2013 Pages: 1 - 1

4. Many drugs can cause alterations in body temperature

   Newsletter Article 31 January 2013 Pages: 2 - 3

5. Antidepressants can impair memory

   Newsletter Article 31 January 2013 Pages: 3 - 3

6. Alteplase

   Newsletter Article 31 January 2013 Pages: 3 - 3

7. Amphotericin B/antibacterials/antineoplastics

   Newsletter Article 31 January 2013 Pages: 3 - 4

8. Antibacterials see Amphotericin B/antibacterials/antineoplastics

   Newsletter Article 31 January 2013 Pages: 4 - 4

9. Antineoplastics see Amphotericin B/antibacterials/antineoplastics

   Newsletter Article 31 January 2013 Pages: 4 - 4

10. Antipsychotics/lithium

    Newsletter Article 31 January 2013 Pages: 4 - 4

11. Aprindine

    Newsletter Article 31 January 2013 Pages: 4 - 4

12. Aspirin overdose

    Newsletter Article 31 January 2013 Pages: 4 - 4

13. Aspirin + paracetamol

    Newsletter Article 31 January 2013 Pages: 4 - 4

14. Azathioprine

    Newsletter Article 31 January 2013 Pages: 4 - 4

15. Bleomycin

    Newsletter Article 31 January 2013 Pages: 4 - 4

16. Bleomycin/etoposide

    Newsletter Article 31 January 2013 Pages: 4 - 5

17. Budesonide

    Newsletter Article 31 January 2013 Pages: 5 - 5

18. Captopril

    Newsletter Article 31 January 2013 Pages: 5 - 5

19. Carbamazepine

    Newsletter Article 31 January 2013 Pages: 5 - 5

20. Cefotetan

    Newsletter Article 31 January 2013 Pages: 5 - 5

21. Ceftriaxone

    Newsletter Article 31 January 2013 Pages: 5 - 5

22. Cilastatin see Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

23. Ciprofloxacin see Warfarin interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

24. Contrast media

    Newsletter Article 31 January 2013 Pages: 6 - 6

25. Cotrimoxazole

    Newsletter Article 31 January 2013 Pages: 6 - 6

26. Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 6 - 6

27. Diamorphine

    Newsletter Article 31 January 2013 Pages: 6 - 6

28. Etoposide see Bleomycin/etoposide

    Newsletter Article 31 January 2013 Pages: 6 - 6

29. Fenofibrate

    Newsletter Article 31 January 2013 Pages: 6 - 7

30. Fusidic acid

    Newsletter Article 31 January 2013 Pages: 7 - 7

31. Granulocyte-macrophage colony-stimulating factor

    Newsletter Article 31 January 2013 Pages: 7 - 7

32. H2 antagonists

    Newsletter Article 31 January 2013 Pages: 7 - 7

33. Heparin

    Newsletter Article 31 January 2013 Pages: 7 - 7

34. Herbal medicine

    Newsletter Article 31 January 2013 Pages: 7 - 7

35. Ibuprofen

    Newsletter Article 31 January 2013 Pages: 7 - 7

36. Imipenem see Cyclosporin interaction

    Newsletter Article 31 January 2013 Pages: 7 - 7

37. Immunoglobulin G

    Newsletter Article 31 January 2013 Pages: 7 - 8

38. Immunotherapy

    Newsletter Article 31 January 2013 Pages: 8 - 8

39. Interferon gamma/interleukin 2

    Newsletter Article 31 January 2013 Pages: 8 - 8

40. Interleukin 2 see Interferon gamma/interleukin 2

    Newsletter Article 31 January 2013 Pages: 8 - 8

41. Lacidipine

    Newsletter Article 31 January 2013 Pages: 8 - 8

42. Lisinopril

    Newsletter Article 31 January 2013 Pages: 8 - 8

43. Lithium see Antipsychotics/lithium

    Newsletter Article 31 January 2013 Pages: 8 - 8

44. Mesalazine

    Newsletter Article 31 January 2013 Pages: 8 - 8

45. Methotrexate

    Newsletter Article 31 January 2013 Pages: 8 - 9

46. Mexiletine see Theophylline interaction

    Newsletter Article 31 January 2013 Pages: 9 - 9

47. Minocycline

    Newsletter Article 31 January 2013 Pages: 9 - 9

48. Mitomycin

    Newsletter Article 31 January 2013 Pages: 9 - 9

49. Moxisylyte

    Newsletter Article 31 January 2013 Pages: 9 - 9

50. Naproxen

    Newsletter Article 31 January 2013 Pages: 9 - 9